NCT03209206 The Effectiveness and Safety of Intravesical Docetaxel Instillation for Prevent Bladder Recurrence Status UNKNOWN Phase PHASE2
NCT03208712 Radium-223 and Atezolizumab in Patients With Urothelial Carcinoma With Bone Metastases Who Have Had Disease Progression After Platinum-Based Chemotherapy Status TERMINATED Phase EARLY_PHASE1
NCT03197571 QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy Status WITHDRAWN Phase PHASE1/PHASE2
NCT03190174 Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers Status COMPLETED Phase PHASE1/PHASE2
NCT03179943 Atezolizumab + Guadecitabine in Patients With Checkpoint Inhibitor Refractory or Resistant Urothelial Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03171493 Trial of Intravesical Measles Virotherapy in Patients With Bladder Cancer Who Are Undergoing Radical Cystectomy Status COMPLETED Phase PHASE1
NCT03170960 Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03093922 A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03062059 The Effectiveness and Safety of Intravesical Gemcitabine Instillation to Prevent Intravesical Recurrence Status UNKNOWN Phase PHASE2
NCT03039413 Copper Cu-64 TP3805 PET/CT in Imaging Patients With Urothelial Cancer Undergoing Surgery or Biopsy Status COMPLETED Phase EARLY_PHASE1
NCT03029832 A Study of MOXR0916 in Combination With Atezolizumab Versus Atezolizumab Alone in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma Who Are Ineligible for Cisplatin-Based Therapy Status TERMINATED Phase PHASE2
NCT03013920 CLE Characteristics of Upper Urinary Tract Urothelial Carcinoma Status COMPLETED Phase N/A
NCT02994758 Development of Diagnostics and Treatment of Urological Cancers Status RECRUITING Phase NA
NCT02989584 A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT02989064 MAGE-A10ᶜ⁷⁹⁶T for Urothelial Cancer, Melanoma or Head and Neck Cancers Status COMPLETED Phase PHASE1
NCT02986867 SAbR Induced Innate Immunity in Urothelial Carcinoma, Melanoma, and Cervical Carcinoma Status COMPLETED Phase NA
NCT02983045 A Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT02968732 Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder Status ACTIVE_NOT_RECRUITING Phase NA